A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...
Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium through 2038.
Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...
There is no increased relapse risk in patients with multiple sclerosis (MS) and comorbid cancer who are receiving immune checkpoint inhibitor (ICI) therapy, results of a small study suggest. MS ...
2don MSN
A CT couple shares same first name and same life-altering disease. Humor helps ‘keep your sanity’
A longtime couple who coincidentally both have a life-altering disease consider themselves “lucky” to have each other. They ...
A centre that provides support for people in Devon with long-term health conditions including multiple sclerosis (MS) and ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Hosted on MSN
Breakthrough multiple sclerosis therapy by UCSF doctor transforms treatment for millions
Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...
Multiple sclerosis (MS) is a debilitating autoimmune disease of the brain and spinal cord. The disease can affect everyone differently, but depending on the progression and severity of the disease, ...
A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...
An appreciation that aberrant immunological responses were important in multiple sclerosis led to the development and approval of interferon-β 1b. Glatiramer acetate and additional formulations of ...
A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results